Page last updated: 2024-10-24

chylomicron remnant clearance

Definition

Target type: biologicalprocess

The process in which a chylomicron remnant is removed from the blood via receptor-mediated endocytosis into liver cells and its constituent parts degraded. [GOC:BHF, GOC:mah, GOC:pde]

Chylomicron remnant clearance is a critical process for lipid homeostasis and involves the removal of chylomicron remnants, which are triglyceride-rich particles derived from dietary fat, from the bloodstream. This process occurs primarily in the liver and involves the following key steps:

1. **Lipoprotein Lipase (LPL) Activity:** Chylomicrons are initially hydrolyzed by LPL, an enzyme primarily found on the surface of capillary endothelial cells in adipose tissue and muscle. LPL releases free fatty acids and glycerol from chylomicrons, reducing their size and transforming them into chylomicron remnants.

2. **Remnant Uptake by Liver:** Chylomicron remnants, now enriched in cholesterol and other lipids, are transported through the bloodstream and eventually reach the liver. They are taken up by hepatocytes via a receptor-mediated endocytosis process.

3. **Receptor-Mediated Endocytosis:** The liver expresses a crucial receptor, the **Apolipoprotein E (ApoE) receptor**, which binds to ApoE, a protein found on the surface of chylomicron remnants. This binding triggers the internalization of the remnant into the hepatocyte.

4. **Lysosomal Degradation:** Once inside the hepatocyte, the chylomicron remnant is directed towards lysosomes, where enzymes break down the remnant into its constituent components, including cholesterol, fatty acids, and phospholipids.

5. **Metabolic Processing:** The breakdown products are then metabolized by the liver. Cholesterol can be used for bile acid synthesis or stored. Fatty acids can be used for energy production or stored as triglycerides.

**Importance of Chylomicron Remnant Clearance:**

- **Lipid Homeostasis:** Efficient clearance of chylomicron remnants prevents their accumulation in the bloodstream, which can lead to hyperlipidemia and cardiovascular disease.
- **Cholesterol Metabolism:** The process provides the liver with cholesterol, which is essential for the production of bile acids, steroid hormones, and cell membranes.
- **Energy Regulation:** The breakdown of chylomicron remnants provides the liver with fatty acids that can be used as an energy source.

**Factors Affecting Remnant Clearance:**

- **Genetic factors:** Variations in the genes encoding LPL, ApoE, and other proteins involved in remnant metabolism can influence clearance efficiency.
- **Dietary factors:** High fat diets can increase the production of chylomicron remnants, potentially overwhelming the liver's clearance capacity.
- **Metabolic diseases:** Conditions such as diabetes and obesity can impair remnant clearance.

**Consequences of Impaired Clearance:**

- **Hyperlipidemia:** Increased levels of chylomicron remnants in the blood can lead to high triglyceride levels and hypercholesterolemia.
- **Atherosclerosis:** Chylomicron remnants can contribute to the formation of atherosclerotic plaques in the arteries, increasing the risk of cardiovascular disease.
- **Liver disease:** Excessive accumulation of remnants in the liver can lead to steatosis (fatty liver) and other liver disorders.

**In summary, chylomicron remnant clearance is a vital process for maintaining lipid homeostasis and protecting against cardiovascular disease. Understanding the intricacies of this process is essential for developing strategies to prevent and treat hyperlipidemia and other metabolic disorders.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Hepatic triacylglycerol lipaseA hepatic triacylglycerol lipase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P11150]Homo sapiens (human)

Compounds (2)

CompoundDefinitionClassesRoles
orlistatorlistat : A carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug.

Orlistat: A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity.
beta-lactone;
carboxylic ester;
formamides;
L-leucine derivative
anti-obesity agent;
bacterial metabolite;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
xen445